In vivo studies of the role of factor VII in hemostasis.

Abstract:

:The effect of both congenital and acquired factor VII deficiency on the cuticle bleeding time (CBT) was evaluated in dogs. The CBT has been previously documented to be a sensitive indicator of factor VIII:C deficiency in hemophilic dogs. Serial CBT determinations were made on normal dogs treated with high-dose warfarin. At 48 hours post-treatment, the CBT was normal, although the factor VII level was less than 1%, whereas the levels of factors II, IX, and X were 44%, 25%, and 17%, respectively. At 120 hours the CBT became abnormal when all vitamin K-dependent clotting factors had dropped to less than 18%. Administration of a plasma concentrate of factors II, IX, and X corrected the CBT, despite the factor VII level remaining at less than 1%. Similar studies in a congenitally factor VII-deficient dog (factor VII less than 2%) confirmed that this deficiency state was not associated with an abnormality of the CBT. Administration of heparin to both normal and factor VII-deficient animals was associated with prolongation of the CBT, but the heparin dose required in the normal animals was substantially higher than in the factor VII-deficient animals. These data do not suggest that factor VII/VIIa has an exclusive role in generating factor Xa, either directly or indirectly, by way of factor IXa generation, in vivo. However, the increase in heparin sensitivity of the factor VII-deficient animals does suggest that factor VII/VIIa may, in some circumstances, present a significant alternative pathway of factor X activation, although the activation pathway involved cannot be determined from the studies performed.

journal_name

Blood

journal_title

Blood

authors

Giles AR,Tinlin S,Brosseau L,Hoogendoorn H

subject

Has Abstract

pub_date

1985-05-01 00:00:00

pages

1197-200

issue

5

eissn

0006-4971

issn

1528-0020

journal_volume

65

pub_type

杂志文章

相关文献

BLOOD文献大全
  • G6PD isoenzyme analysis of myeloid and lymphoid cells in human multilineage colonies.

    abstract::Some multilineage hemopoietic colonies contain, in addition to myeloid cells, T lymphocytes. These proliferate extensively in liquid suspension culture under the influence of a T cell growth factor provided by phytohemagglutinin-T cell-conditioned medium (PHA-TCM). The clonal origin of these myeloid and lymphoid compo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lim B,Jamal N,Tritchler D,Messner HA

    更新日期:1984-06-01 00:00:00

  • Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2.

    abstract::In childhood acute lymphoblastic leukemia (ALL), early response to treatment is a powerful prognostic indicator. To identify genes associated with this response, we analyzed gene expression of diagnostic lymphoblasts from 189 children with ALL and compared the findings with minimal residual disease (MRD) levels on day...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-01-0322

    authors: Flotho C,Coustan-Smith E,Pei D,Iwamoto S,Song G,Cheng C,Pui CH,Downing JR,Campana D

    更新日期:2006-08-01 00:00:00

  • Interferon-gamma upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism.

    abstract::Interleukin-8 (IL-8) is a neutrophil chemotactic and activating cytokine that is produced in response to several stimuli. Because monocytic cells are important producers of IL-8, we investigated whether interferon-gamma (IFN-gamma), a potent inducer of activation and differentiation of mononuclear phagocytes, affected...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bosco MC,Gusella GL,Espinoza-Delgado I,Longo DL,Varesio L

    更新日期:1994-01-15 00:00:00

  • Minimal residual disease is an independent predictor for 10-year survival in CLL.

    abstract::Minimal residual disease (MRD) negativity, defined as <1 chronic lymphocytic leukemia (CLL) cell detectable per 10 000 leukocytes, has been shown to independently predict for clinical outcome in patients receiving combination chemoimmunotherapy in the frontline setting. However, the long-term prognostic value of MRD s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-05-714162

    authors: Kwok M,Rawstron AC,Varghese A,Evans PA,O'Connor SJ,Doughty C,Newton DJ,Moreton P,Hillmen P

    更新日期:2016-12-15 00:00:00

  • Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury.

    abstract::Ischemia/reperfusion (I/R) injury in the kidney is a major cause of acute kidney injury (AKI) in humans and is associated with significantly high mortality. To identify genes that modulate kidney injury and repair, we conducted genome-wide expression analysis in the rat kidneys after I/R and found that the mRNA levels...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-338061

    authors: Krishnamoorthy A,Ajay AK,Hoffmann D,Kim TM,Ramirez V,Campanholle G,Bobadilla NA,Waikar SS,Vaidya VS

    更新日期:2011-08-18 00:00:00

  • Restoration of superoxide generation to a chronic granulomatous disease-derived B-cell line by retrovirus mediated gene transfer.

    abstract::Failure of a superoxide generating system, the NADPH oxidase, present in neutrophils and other phagocytes gives rise to chronic granulomatous disease (CGD), a group of single-gene inherited disorders all characterized by an extreme susceptibility to pyogenic infection, with potentially fatal consequences. About 30% of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Thrasher A,Chetty M,Casimir C,Segal AW

    更新日期:1992-09-01 00:00:00

  • Deletion of the zinc-binding motif of CD13/aminopeptidase N molecules results in loss of epitopes that mediate binding of inhibitory antibodies.

    abstract::The myeloid cell-surface glycoprotein CD13/aminopeptidase N (APN; EC 3.4.11.2) contains a pentapeptide (HExxH) in its extracellular domain that is characteristic of many zinc-dependent metalloproteinases. This region contains residues important for zinc binding and constitutes part of the catalytic domain of several m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ashmun RA,Shapiro LH,Look AT

    更新日期:1992-06-15 00:00:00

  • Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets.

    abstract::Hematopoietic fate maps in the developing mouse embryo remain imprecise. Definitive, adult-type hematopoiesis first appears in the fetal liver, then progresses to the spleen and bone marrow. Clonogenic common lymphoid progenitors and clonogenic common myeloid progenitors (CMPs) in adult mouse bone marrow that give ris...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.627

    authors: Traver D,Miyamoto T,Christensen J,Iwasaki-Arai J,Akashi K,Weissman IL

    更新日期:2001-08-01 00:00:00

  • Point mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria (Günther's disease).

    abstract::Congenital erythropoietic porphyria (Günther's disease) is a rare disorder of heme biosynthesis inherited in an autosomal recessive fashion. The molecular abnormality responsible for the characteristic defect in uroporphyrinogen III synthase activity was investigated in two patients. For the first patient, complementa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Deybach JC,de Verneuil H,Boulechfar S,Grandchamp B,Nordmann Y

    更新日期:1990-05-01 00:00:00

  • Speaking a common language in MDS/MPNs.

    abstract::In this issue of Blood, Savona and an international consortium of clinical investigators propose uniform response criteria for treatment trials enrolling adult patients with myelodysplastic/myeloproliferative neoplasms (MDS/MPNs). Such a proposal is needed because new drugs are finally being tested in these rare “over...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-02-626473

    authors: Steensma DP

    更新日期:2015-03-19 00:00:00

  • Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.

    abstract::Outcome in multiple myeloma is highly variable and a better understanding of the factors that influence disease biology is essential to understand and predict behavior in individual patients. In the present study, we analyzed combined genomewide DNA methylation and gene expression data of patients treated in the Medic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-03-487884

    authors: Kaiser MF,Johnson DC,Wu P,Walker BA,Brioli A,Mirabella F,Wardell CP,Melchor L,Davies FE,Morgan GJ

    更新日期:2013-07-11 00:00:00

  • Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.

    abstract::We have performed a retrospective analysis of the development of T- and B-cell functions after HLA-nonidentical T-cell-depleted bone marrow transplantation (BMT) performed in 193 patients with severe combined immunodeficiency (SCID) at 18 European centers between December 1982 and December 31, 1993. One hundred sixtee...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Haddad E,Landais P,Friedrich W,Gerritsen B,Cavazzana-Calvo M,Morgan G,Bertrand Y,Fasth A,Porta F,Cant A,Espanol T,Müller S,Veys P,Vossen J,Fischer A

    更新日期:1998-05-15 00:00:00

  • Can Treg elimination enhance NK cell therapy for AML?

    abstract::In this issue of Blood, Bachanova et al describe how modulation of the inhibitory tumor environment may enhance natural killer (NK) cell clinical activity and produce encouraging results in the treatment of refractory acute myeloid leukemia (AML). NK cells are highly proliferative, early responders of the innate immun...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-05-570291

    authors: Rooney CM

    更新日期:2014-06-19 00:00:00

  • CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.

    abstract::Adoptive transfer of T cells genetically modified to express chimeric antigen receptors (CARs) targeting CD19 has produced impressive results in treating patients with B-cell malignancies. Although these CAR-modified T cells target the same antigen, the designs of CARs vary as well as several key aspects of the clinic...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-02-629063

    authors: Park JH,Geyer MB,Brentjens RJ

    更新日期:2016-06-30 00:00:00

  • Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

    abstract::Lymphatic endothelial cells (LECs) induce peripheral tolerance by direct presentation to CD8 T cells (T(CD8)). We demonstrate that LECs mediate deletion only via programmed cell death-1 (PD-1) ligand 1, despite expressing ligands for the CD160, B- and T-lymphocyte attenuator, and lymphocyte activation gene-3 inhibitor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-427013

    authors: Tewalt EF,Cohen JN,Rouhani SJ,Guidi CJ,Qiao H,Fahl SP,Conaway MR,Bender TP,Tung KS,Vella AT,Adler AJ,Chen L,Engelhard VH

    更新日期:2012-12-06 00:00:00

  • Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets.

    abstract::Human blood contains 2 populations of dendritic cells (DCs): plasmacytoid and myeloid (mDC). mDCs are subdivided into 3 subsets using the surface markers CD16, CD1c, and BDCA-3. Their role as pathogen sentinels and adjuvant targets was tested by phenotypic and functional analysis. We show that mDC subsets are immature...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-038422

    authors: Piccioli D,Tavarini S,Borgogni E,Steri V,Nuti S,Sammicheli C,Bardelli M,Montagna D,Locatelli F,Wack A

    更新日期:2007-06-15 00:00:00

  • Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients.

    abstract::A study in 121 infants with severe combined immunodeficiency (SCID) was performed to determine the prevalence of an engraftment by transplacentally acquired maternal T cells and to explore clinical and immunological findings related to this abnormality. Each newly diagnosed patient with SCID presenting with circulatin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.6.1847

    authors: Müller SM,Ege M,Pottharst A,Schulz AS,Schwarz K,Friedrich W

    更新日期:2001-09-15 00:00:00

  • Inhibition of human bone marrow fibroblast colony formation by leukemic cells.

    abstract::The number of bone marrow fibroblast colony formations decreases in most cases of acute leukemia before the initiation of chemotherapy. This study was undertaken to clarify the mechanism of suppression of fibroblast colony formation in leukemic patients. Titration of the number of bone marrow cells did not indicate a ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nagao T,Yamauchi K,Komatsuda M,Noguchi K,Shimizu M,Yonekura S,Nozaki H

    更新日期:1983-12-01 00:00:00

  • Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS.

    abstract::Whole saliva samples collected from available people at risk in Boston for infection with human T-lymphotropic virus type III (HTLV-III/LAV), from late 1984 through early 1985, were analyzed for the presence of antibodies to viral proteins. Fourteen of 20 (70%) acquired immunodeficiency syndrome (AIDS) patients and 14...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Archibald DW,Zon L,Groopman JE,McLane MF,Essex M

    更新日期:1986-03-01 00:00:00

  • In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease.

    abstract::The cellular constituents in lymph nodes and spleens of patients with Hodgkin's disease were studied with a series of monoclonal antibodies directed against human thymocyte, peripheral T-cell, and la antigens. Utilizing both an immunoperoxidase technique on frozen tissue sections and indirect immunofluorescence on cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Poppema S,Bhan AK,Reinherz EL,Posner MR,Schlossman SF

    更新日期:1982-02-01 00:00:00

  • Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.

    abstract::Adenovirus-transduced CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (CD34-TRAIL+ cells) exert potent antitumor activity. To further investigate the mechanism(s) of action of CD34-TRAIL+ cells, we analyzed their homing properties as well as antitumor and antivascular effe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-08-239632

    authors: Lavazza C,Carlo-Stella C,Giacomini A,Cleris L,Righi M,Sia D,Di Nicola M,Magni M,Longoni P,Milanesi M,Francolini M,Gloghini A,Carbone A,Formelli F,Gianni AM

    更新日期:2010-03-18 00:00:00

  • Epidermis instructs skin homing receptor expression in human T cells.

    abstract::The localization of memory T cells to human skin is essential for long-term immune surveillance and the maintenance of barrier integrity. Although the mechanisms controlling memory T-cell migration to peripheral tissues are poorly understood, the current paradigm includes the localized secretion of "imprinting" signal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-05-433037

    authors: McCully ML,Ladell K,Hakobyan S,Mansel RE,Price DA,Moser B

    更新日期:2012-11-29 00:00:00

  • Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.

    abstract::Induction of red blood cell (RBC) fetal hemoglobin (HbF; α2γ2) ameliorates the pathophysiology of sickle cell disease (SCD) by reducing the concentration of sickle hemoglobin (HbS; α2βS2) to inhibit its polymerization. Hydroxyurea (HU), the only US Food and Drug Administration (FDA)-approved drug for SCD, acts in part...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-11-814335

    authors: Zhang Y,Paikari A,Sumazin P,Ginter Summarell CC,Crosby JR,Boerwinkle E,Weiss MJ,Sheehan VA

    更新日期:2018-07-19 00:00:00

  • Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment.

    abstract::A retrospective study compared posttransplant engraftment parameters in 203 patients with myelofibrosis (MF) with those in a population of 203 matched controls without MF. There were no significant differences between these groups in the proportions of patients who died without achieving engraftment and in the disease...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Soll E,Massumoto C,Clift RA,Buckner CD,Appelbaum FR,Storb R,Sale G,Hackman R,Martin P

    更新日期:1995-12-15 00:00:00

  • Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1.

    abstract::Murine IgM monoclonal antibody STRO-1 identifies a cell surface antigen expressed by stromal elements in human bone marrow (BM). STRO-1 binds to approximately 10% of BM mononuclear cells, greater than 95% of which are nucleated erythroid precursors, but does not react with committed progenitor cells (colony-forming un...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Simmons PJ,Torok-Storb B

    更新日期:1991-07-01 00:00:00

  • Modification of hemoglobin by ninhydrin.

    abstract::The Strecker degradation reaction was evaluated as a means of modifying hemoglobin in vitro, utilizing ninhydrin as a model compound. Ninhydrin led to modification of hemoglobin (when incubated with hemoglobin or red cells) at physiologic temperature and pH. Isoelectric focusing documented the formation of new hemoglo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kokkini G,Stevens VJ,Peterson CM,Cerami A

    更新日期:1980-10-01 00:00:00

  • Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia.

    abstract::The risk of development of CNS leukemia was investigated in 153 adults with acute lymphocytic leukemia (ALL) who received systemic combination chemotherapy without CNS prophylaxis. Overall, 31 patients (20%) developed CNS leukemia after a median of 6 months of therapy; the estimated 1-year incidence of CNS leukemia wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kantarjian HM,Walters RS,Smith TL,Keating MJ,Barlogie B,McCredie KB,Freireich EJ

    更新日期:1988-11-01 00:00:00

  • The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells.

    abstract::The Kell blood group is one of the major antigenic systems in human red blood cells. To determine the location of the Kell gene on human chromosomes, panels containing genomic DNA of human-hamster somatic cell hybrids were hybridized with radiolabeled cDNA probe specific for the Kell locus. Only the samples containing...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lee S,Zambas ED,Marsh WL,Redman CM

    更新日期:1993-05-15 00:00:00

  • Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B.

    abstract::Factor IXAlabama is a variant factor IX molecule responsible for a clinically moderate form of hemophilia B. Twenty-five kilobases (kb) of the variant gene, including seven exons coding for the structural protein, were cloned and characterized. The restriction map and the arrangement of coding regions are identical to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Davis LM,McGraw RA,Ware JL,Roberts HR,Stafford DW

    更新日期:1987-01-01 00:00:00

  • Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.

    abstract::Forty-nine patients with primary myelodysplastic syndromes (MDS) were subclassified according to French-American-British (FAB) Cooperative Group criteria. Eight patients had acquired idiopathic sideroblastic anemia (AISA), ten had chronic myelomonocytic leukemia (CMMoL), 14 had refractory anemia (RA), nine had refract...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jacobs RH,Cornbleet MA,Vardiman JW,Larson RA,Le Beau MM,Rowley JD

    更新日期:1986-06-01 00:00:00